The results of the present study suggest that it may be possible to use the PHP.eB system and adult IRSp53 re-expression in the treatment of IRSp53-related brain disorders and, more broadly, other brain disorders that can benefit from the re-expression of target genes via BBB penetration. This evidence concerns the gene BAIAP2 and brain disorder.